Discover
IKT
Inhibikase Therapeutics, Inc.
2.35
2 x 1.75
2 x 3.03
bid
ask
-
0.06
2.70%
12:31 PM
timesize
| Ytd | 14.39% | |
| 1y | 30.28% |
2.34
day range
2.44
1.33
52 week range
2.54
| Open | 2.41 | Prev Close | 2.41 | Low | 2.34 | High | 2.44 | Mkt Cap | 327.21M |
| Vol | 59.68K | Avg Vol | 781.50K | EPS | -0.44 | P/E | N/A | Forward P/E | -11.84 |
| Beta | 0.95 | Short Ratio | 0.17 | Inst. Own | 11.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 2.21 | 200-d Avg | 1.85 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 21.05M | ||
| Research and Development Expense | 13.39M | ||
| Selling, General and Administrative Expense | 7.66M | ||
| Operating Income | -21.05M | ||
| Net Income | -19.59M | ||
| Net Income Common Stock | -19.59M | ||
| Net Income Common Stock (USD) | -19.59M | ||
| Consolidated Income | -19.59M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -19.59M | ||
| Earning Before Interest & Taxes (USD) | -19.59M | ||
| Weighted Average Shares | 174.57M | ||
| Weighted Average Shares Diluted | 174.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 31.21M | ||
| Cash and Equivalents (USD) | 31.21M | ||
| Investments | 127.81M | ||
| Investments Current | 127.81M | ||
| Current Assets | 162.34M | ||
| Total Assets | 163.59M | ||
| Current Liabilities | 10.26M | ||
| Total Liabilities | 10.26M | ||
| Accumulated Retained Earnings (Deficit) | -178.65M | ||
| Accumulated Other Comprehensive Income | -72.75K | ||
| Shareholders Equity | 153.33M | ||
| Shareholders Equity (USD) | 153.33M | ||
| Assets Non-Current | 1.24M | ||
| Trade and Non-Trade Payables | 991.72K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -14.49K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -18.37M | ||
| Net Cash Flow from Investing | -5.91M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -5.91M | ||
| Net Cash Flow from Operations | -12.44M | ||
| Share Based Compensation | 5.35M | ||